Cancer
-
Combination treatment could attack aggressive prostate cancers
An experimental cancer drug combined with targeted hormone treatment could treat an aggressive group of prostate cancers, a European conference has heard. Read more
-
Access to cancer medicines and trials vary across Europe
Access to cancer medicines varies widely across Europe both for new drugs in development and for currently approved drugs, a conference has heard. Read more
-
Breast cancer patients should receive brain scans
Women with breast cancer should receive brain scans to ensure metastatic disease is identified while it is asymptomatic, according to a new analysis. Read more
-
plasmaMATCH trial success for breast cancer patients
A blood test that can identify a variety of mutations in advanced breast cancer can match women to effective targeted treatments, according to the early results of a major clinical trial. Read more
-
Genetic vulnerability in breast cancer cells discovered
A genetic vulnerability that is present in nearly 10% of all breast cancer tumours has been discovered, scientists have announced. Read more
-
World falling behind on non-communicable diseases
Most of the world is falling behind on promises to tackle chronic and non-communicable diseases – and the COVID-19 pandemic has made this worse, according to a major analysis. Read more
-
Social smokers face disproportionate lung disease and cancer risk
So-called “social smokers” are more than twice as likely to die of lung disease and more than eight times as likely to die from lung cancer than non-smokers, a European conference hears today. Read more
-
Immunotherapy hope for aggressive pancreatic cancer
An aggressive form of pancreatic cancer could respond to immunotherapy, according to a study published today. Read more
-
Surge in melanoma skin cancer death rates
Melanoma skin cancer death rates in the UK have increased 150% since the 1970s, with men being affected more, according to new analysis by Cancer Research UK. Read more
-
Lives saved with reduced age breast screening
Breast screening women in their forties reduces breast cancer mortality, with little increase in overdiagnosis, according to a UK study out today. Read more
